Chosa Oncology AB (XSAT:CHOSA) Days Payable: 0.00 (As of Mar. 2026)


XSAT:CHOSA Chosa Oncology AB XSAT:CHOSA
31 GF Score
Price kr0.80
View Full Analysis

What is Chosa Oncology AB Days Payable?

Chosa Oncology AB XSAT:CHOSA +2.56% 31 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 31/100. Among 704 Biotechnology companies, Chosa Oncology AB ranks worse than 142045.31% on this metric.

Chosa Oncology AB's average Accounts Payable for the three months ended in Mar. 2026 was kr1.74 Mil. Chosa Oncology AB's Cost of Goods Sold for the three months ended in Mar. 2026 was kr0.00 Mil.

The historical rank and industry rank for Chosa Oncology AB's Days Payable or its related term are showing as below:

XSAT:CHOSA's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Chosa Oncology AB's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Chosa Oncology AB Days Payable Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Days Payable Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSAT:CHOSA vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Chosa Oncology AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chosa Oncology AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Chosa Oncology AB's Days Payable falls into.


XSAT:CHOSA
31GF Score
Chosa Oncology AB XSAT:CHOSA
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chosa Oncology AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (1.67 + 2.714) / 2 ) / -4.607*365
=2.192 / -4.607*365
=N/A

Chosa Oncology AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (2.714 + 0.757) / 2 ) / 0*365 / 4
=1.7355 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Chosa Oncology AB (XSAT:CHOSA) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chosa Oncology AB and its competitors. According to the industry distribution chart, Chosa Oncology AB ranks #999999 out of 704 companies in the Biotechnology industry.
Is Chosa Oncology AB's Days Payable too high?
Chosa Oncology AB's current Days Payable is 0.00. Based on the distribution chart, Chosa Oncology AB ranks #999999 out of 704 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chosa Oncology AB ranks #999999 out of 704 companies for Days Payable. This places Chosa Oncology AB in the lower half of its industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chosa Oncology AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chosa Oncology AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current Days Payable of 0.00. The current Days Payable is 0.00. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
31GF Score

Get the complete analysis for XSAT:CHOSA

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.80
Price